Platinum-Taxol non-cross resistance in epithelial ovarian cancer.

The aim of this study was to assess the clinical evidence for platinum-Taxol non-cross-resistance in patients with epithelial ovarian cancer. Unlike other studies, only patients who had demonstrably progressive disease on platinum therapy were analysed. Patients received 135-200 mg m-2 of Taxol over...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Gore, M. E., Preston, N., A'Hern, R. P., Hill, C., Mitchell, P., Chang, J., Nicolson, M.
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 1995
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033816/
https://ncbi.nlm.nih.gov/pubmed/7779729
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы